A detailed history of Central Pacific Bank Trust Division transactions in United Therapeutics Corp stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 350 shares of UTHR stock, worth $124,509. This represents 0.02% of its overall portfolio holdings.

Number of Shares
350
Previous 420 16.67%
Holding current value
$124,509
Previous $134 Million 6.25%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$311.04 - $363.55 $21,772 - $25,448
-70 Reduced 16.67%
350 $125 Million
Q2 2024

Jul 30, 2024

SELL
$228.26 - $319.04 $35,380 - $49,451
-155 Reduced 26.96%
420 $134 Million
Q1 2024

May 02, 2024

BUY
$210.76 - $249.51 $121,187 - $143,468
575 New
575 $131 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Central Pacific Bank Trust Division Portfolio

Follow Central Pacific Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Pacific Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Central Pacific Bank Trust Division with notifications on news.